Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
Max R. O’Donnell(Columbia University Irving Medical Center), C. Robert Horsburgh, Charlotte Kvasnovsky(South African Medical Research Council), Nesri Padayatchi(Centre for the AIDS Programme of Research in South Africa), Iqbal Master(South African Medical Research Council), Lise Werner(South African Medical Research Council)
Cited by 114
Related Papers
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|medRxiv|2020|374
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal
|PLoS Medicine|2015|299
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids
|American Journal of Respiratory and Critical Care Medicine|2021|295
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
|American Journal of Respiratory and Critical Care Medicine|2009|266